期刊文献+

血瘀型骨质疏松症的方药配伍规律探讨 被引量:7

Discussion on the rule of prescription compatibility of blood stasis type osteoporosis
下载PDF
导出
摘要 目的通过数据挖掘探讨中医药治疗血瘀型骨质疏松症的方药配伍规律。方法收集整理中国期刊全文数据库等数据库中公开发表的治疗血瘀型骨质疏松症的文献,设定筛选条件,筛选有效中药处方,并对方药名称进行规范,应用频数统计、聚类分析、因子分析、关联规则算法对血瘀型骨质疏松症的核心用药及组方规律进行探讨研究及系统分析。结果筛选出治疗血瘀型骨质疏松症的有效文献共127篇,共涉中药160味,药物出现总频次1 459次。共提取出药物组合公因子10个,采用组间联接的聚类分析方法共得到5类药物组合,关联规则分析的核心用药组合为12组。结论血瘀型骨质疏松症血瘀型骨质疏松症为本虚标实之证,与肝脾肾有关,与肾脏关系最为密切。治疗中应当把握以肾虚为要,以瘀实为次,补虚为先、攻邪为次;同时兼顾肝脾,重视补气及行气药物的应用,气血并调。 Objective To explore the compatibility of traditional Chinese medicine in the treatment of blood stasis type osteoporosis by data mining.Methods The published literatures concerning the treatment of blood stasis type osteoporosis in the database of Chinese journals with full text and other databases were collected and sorted.The screening condition was set,the effective Chinese medicine prescriptions were screened,and the prescription names were standardized.The core medication and prescription rules of blood stasis type osteoporosis were discussed with frequency statistics,cluster analysis,factor analysis and association rule algorithm,and system analysis.Results A total of 127 effective literatures for the treatment of osteoporosis of blood stasis type were selected,involving 160 kinds of traditional Chinese medicine,and the total frequency of drug occurrence was 1459 times.A total of 10 common factors of drug combinations were extracted,and 5 drug combinations were obtained by cluster analysis method of inter group linkage.The core drug combination of association rule analysis was 12 groups.Conclusion Blood stasis type osteoporosis is the syndrome of deficiency and excess,which is related to the liver,spleen and kidney,and is most closely related to kidney.In the treatment,we should take kidney deficiency as the main point,blood stasis as the second,tonifying deficiency as the first and attacking pathogenic factors as the second.At the same time,we should take the liver and spleen into account,pay attention to the application of Qi tonifying and Qi promoting drugs,and regulate Qi and blood simultaneously.
作者 张芸 薛景才 郑平原 仪庆春 王均宁 王福良 王文波 ZHANG Yun;XUE Jingcai;ZHENG Pingyuan;YI Qingchun;WANG Junning;WANG Fuliang;WANG Wenbo(Shandong University of Traditional Chinese Medicine,Ji’nan 250355;Weihaiwei People's Hospital,Weihai 264200;The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Ji*nan 250012;Anqiu Hospital of Traditional Chinese Medicine,Weifang 261200,Shandong,China)
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2021年第7期1036-1041,共6页 Chinese Journal of Osteoporosis
基金 国家自然基金青年基金(81503594) 山东省医药卫生科技发展计划项目(2018WS094)。
关键词 中医中药 血瘀 骨质疏松 配伍 聚类分析 关联规则 traditional Chinese medicine stasis of blood osteoporosis compatibility cluster analysis association rules
  • 相关文献

参考文献17

二级参考文献161

共引文献1674

同被引文献152

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部